├── README.md
└── LICENSE


/README.md:
--------------------------------------------------------------------------------
 1 | # Notes
 2 | Notes for ReactivePlatform User.
 3 | 
 4 | 请在单独的issue中开启自己的对应笔记，请合理使用，如果需要整理为CaseStudy的，请在该Issue完成后，将其关闭，并编写完整的CaseStudy.md，同时将其附送到 https://github.com/ReactivePlatform/CaseStudy
 5 | 
 6 | 如果某个Issue不能被整理为一个ReactivePlatform的CaseStudy，如读书笔记等，请在其关闭后将其整理为单独的Note.md。
 7 | 并且将其PullRequest到当前的Repo中。
 8 | 
 9 | ## 说明
10 | 
11 | ### 1 目录结构
12 | 
13 | 请使用`/username/xxx.md`。其中username为单个用户的专有目录。
14 | 
15 | 
16 | ### 2 文档格式
17 | 
18 | 文档格式请采用markdown编写，格式统一为：
19 | 
20 | 文件名：XXX.md
21 | 
22 | ```
23 | #标题
24 | 
25 | |作者|更新日期|
26 | |----|--------|
27 | |@auther|20xx-xx-xx|
28 | |ref|#原始的issue链接|
29 | 
30 | ---------------
31 | 
32 | 正文部分
33 | ```
34 | 
35 | ### 提交方式
36 | 
37 | 请通过提交FullRequest的方式提交。
38 | 


--------------------------------------------------------------------------------
/LICENSE:
--------------------------------------------------------------------------------
 1 | The MIT License (MIT)
 2 | 
 3 | Copyright (c) 2016 The Reactive Platform
 4 | 
 5 | Permission is hereby granted, free of charge, to any person obtaining a copy
 6 | of this software and associated documentation files (the "Software"), to deal
 7 | in the Software without restriction, including without limitation the rights
 8 | to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
 9 | copies of the Software, and to permit persons to whom the Software is
10 | furnished to do so, subject to the following conditions:
11 | 
12 | The above copyright notice and this permission notice shall be included in all
13 | copies or substantial portions of the Software.
14 | 
15 | THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
16 | IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
17 | FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
18 | AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
19 | LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
20 | OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
21 | SOFTWARE.
22 | 


--------------------------------------------------------------------------------